Vincerx Pharma Balance Sheet Health
Financial Health criteria checks 4/6
Vincerx Pharma has a total shareholder equity of $9.1M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $14.9M and $5.8M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$10.09m |
| Equity | US$9.11m |
| Total liabilities | US$5.84m |
| Total assets | US$14.95m |
Recent financial health updates
Here's Why Vincerx Pharma (NASDAQ:VINC) Must Use Its Cash Wisely
Aug 21
Can Vincerx Pharma (NASDAQ:VINC) Afford To Invest In Growth?
Jul 18Can Vincerx Pharma (NASDAQ:VINC) Afford To Invest In Growth?
Mar 30Recent updates
Here's Why Vincerx Pharma (NASDAQ:VINC) Must Use Its Cash Wisely
Aug 21Can Vincerx Pharma (NASDAQ:VINC) Afford To Invest In Growth?
Jul 18Can Vincerx Pharma (NASDAQ:VINC) Afford To Invest In Growth?
Mar 30Can Vincerx Pharma (NASDAQ:VINC) Afford To Invest In Growth?
Sep 22Is Vincerx Pharma (NASDAQ:VINC) In A Good Position To Invest In Growth?
Jun 24Vincerx Pharma doses first patient in early-stage VIP152 cancer study
Jun 03Financial Position Analysis
Short Term Liabilities: VINC's short term assets ($11.7M) exceed its short term liabilities ($5.4M).
Long Term Liabilities: VINC's short term assets ($11.7M) exceed its long term liabilities ($415.0K).
Debt to Equity History and Analysis
Debt Level: VINC is debt free.
Reducing Debt: VINC had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: VINC has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: VINC has less than a year of cash runway if free cash flow continues to reduce at historical rates of 26.7% each year